Share on StockTwits

Minerva Neurosciences (NASDAQ:NERV) CFO Geoff Race purchased 33,333 shares of the stock in a transaction dated Tuesday, July 1st. The shares were purchased at an average cost of $6.00 per share, with a total value of $199,998.00. Following the completion of the acquisition, the chief financial officer now directly owns 206,648 shares in the company, valued at approximately $1,239,888. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

Minerva Neurosciences (NASDAQ:NERV) traded down 0.67% during mid-day trading on Wednesday, hitting $5.93. The stock had a trading volume of 43,059 shares. Minerva Neurosciences has a 52 week low of $5.75 and a 52 week high of $6.38. The stock has a 50-day moving average of $5.99 and a 200-day moving average of $5.99. The company’s market cap is $108.4 million.

Minerva Neurosciences, Inc is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (NASDAQ:NERV), diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.